Plain-English translation of NCT05502887 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — meaning researchers will collect health information and blood samples from up to 1,000 patients with newly diagnosed blood cancers. The goal is to understand how blood cancers and their treatments affect blood vessels in the body, and to find early warning signs that might help doctors prevent or manage complications.
Blood cancers and their treatments can damage the delicate cells that line blood vessels, sometimes leading to serious complications. This study exists to better understand these blood vessel problems before they happen, so doctors can identify at-risk patients earlier and develop better ways to prevent or treat these complications.
You likely qualify if…
You likely don't qualify if…
If you join, you will be enrolled in a long-term registry, meaning your medical information, blood samples, and health outcomes will be tracked over time as part of the research. You will likely have blood draws and routine clinical visits; the exact schedule will depend on your cancer treatment plan and the participating center. This is not a treatment trial — you will continue receiving your regular cancer care while researchers monitor your blood vessel health and collect data.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
Germany